Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-61.37	29.28	75.78
Graham Fair Price	-60.27	27971.59	70397.06
PEG	1108.58	-0.29	0.02
Price/Book	-10.70	0.23	0.25
Price/Cash Flow	15.45	-7.56	6.55
Prices/Earnings	464.45	34.05	-6.03
Price/Sales	-8.45	0.72	0.79
Price/FCF	15.45	-7.56	6.55
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	157.29	0.06	0.02
Operating Margin	-75.11	< 0.005	-0.04
ROA	-84.18	< 0.005	< 0.005
ROE	-0.01	< 0.005	-84.18
ROIC	< 0.005	0.02	273.37
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	-0.04	-24.15
Dividends QOQ	-1.00	-1.00	-0.21
EBIT QOQ	-2.01	1.24	-38.08
EPS QOQ	-2.48	1.16	-53.30
FCF QOQ	0.12	-1.77	1399.56
Revenue QOQ	-0.03	-0.03	10.05
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	94.71	103.88	9.68
Days Sales Outstanding (DSO)	45.79	49.41	7.91
Inventory Turnover	0.95	0.87	-8.83
Debt/Capitalization	0.34	0.35	2.49
Quick Ratio	0.69	0.67	-3.07
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	145197.77	145048.05	-0.10
Cash	18149.67	16013.26	-11.77
Capex	-2503.40	-4622.62	-84.65
Free Cash Flow	5588.13	-4317.78	-22.73
Revenue	46403.61	45214.56	-2.56
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.50	1.50	-0.07
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	49.49	20.28	-59.02
Naive Interpretation	Member

06 - Financial Health · Weak

Rating